Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2733]

FDA approves gemtuzumab ozogamicin for CD33-positive AML in paediatric patients

FDA approves gemtuzumab ozogamicin for CD33-positive AML in paediatric patients

TERAVOLT registry tracks outcomes among thoracic cancer patients sickened by COVID-19

TERAVOLT registry tracks outcomes among thoracic cancer patients sickened by COVID-19

Cancer patients less likely to be prescribed cardioprotective medications

Cancer patients less likely to be prescribed cardioprotective medications

New technique may quickly and accurately predict effective therapies in solid tumours

New technique may quickly and accurately predict effective therapies in solid tumours

Drug with new approach on impeding DNA repair shows promise in first clinical trial

Drug with new approach on impeding DNA repair shows promise in first clinical trial

Novel treatment for mesothelioma shows promise for patients

Novel treatment for mesothelioma shows promise for patients

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies

Cytokine implicated in HLH treatment resistance

Cytokine implicated in HLH treatment resistance

Phase II trial leads to practice changing milestone for advanced anal cancer

Phase II trial leads to practice changing milestone for advanced anal cancer

EHA 2020: A paradigm shift for the treatment of newly diagnosed older acute myeloid leukaemia patients

EHA 2020: A paradigm shift for the treatment of newly diagnosed older acute myeloid leukaemia patients

More from ecancer